is rybelsus glp 1 Health Canada approves Rybelsus, the first oral GLP-1 pill to lower cardiovascular risk in adults with Type 2 diabetes. #longevity #GLP1 #diabetes #cardiometabolic #hearthealth #metabolichealth #obesitycare #digitalhealth #biotechnews #healthinnovation Novo's Rybelsus gains FDA expansion

L-carnitine Enzymatic Assay Kit is the enzymatic assay based on AOAC official method to determine L-carnitine in baby and toddler formula, suitable for use in dairy factories, dairy labs and food authorities Key facts of the L-carnitine Enzymatic Assay Kit Ready to use test kit based on enzymatic assay

doi:10.1016/j.vph.2016.03.007 Go AS, Hylek EM, Phillips KA, et al

According to the manufacturer, the product is described as featuring: A plant-based formula Transdermal application format Ingredients including berberine and chromium The manufacturer states the patches are designed with the goal of supporting: Appetite signaling pathways Metabolic function Balanced wellness Manufacturing Context (Per the Company) According to the NuraPatch FAQ, the product is "made in facilities that follow FDA guidelines for dietary supplements." The company states that as a "plant-based wellness product and not a prescription drug, it does not need separate FDA approval for drugs." This language aligns with standard dietary supplement regulatory positioning under the Dietary Supplement Health and Education Act (DSHEA)

And could they extend not just metabolic health, but also healthspanthe years lived in good health